Jabil Inc Stock Price, News & Analysis

Jabil Inc. (NYSE: JBL) has announced plans to establish its second factory in Gujarat, India, following a Memorandum of Understanding (MoU) signed in November 2024. The company, which operates over 100 sites across 25+ countries, will explore building a post-wafer fabrication silicon photonics facility with advanced co-packaged optics capabilities.

The announcement was made during the Gujarat SemiConnect IESA Vision Summit in Gandhinagar, with Gujarat Chief Minister Bhupendra Patel present. The expansion aims to create jobs and boost domestic semiconductor industry development through Jabil's photonics expertise.

Jabil brings over a decade of experience in photonics, specializing in designing devices and systems, developing amplifiers, transceivers, laser packages, and optical networking products. The company serves diverse industries including semiconductor equipment, data centers, automotive, healthcare, and warehouse automation.

Jabil (NYSE: JBL) has released its fiscal year 2024 Sustainability Progress Report, showcasing significant environmental achievements. The company has reduced enterprise-wide greenhouse gas emissions by 46% compared to its 2019 baseline, positioning it to exceed its 50% reduction target by 2030.

Key highlights include:

• 10% of applicable sites achieving 90% or more landfill diversion
• Over 589,000 volunteer hours completed in local communities during 2024
• Expanded Scope 3 indirect GHG emission inventory
• Joined the Circular Electronics Partnership (CEP)
• Acquired Mikros Technologies for energy-efficient cooling solutions

The report aligns with global standards including GRI, SASB, and TCFD, demonstrating Jabil's commitment to environmental and social responsibility. Strategic partnerships with companies like Thermo Fisher Scientific and Ocado reinforce their dedication to sustainability and supporting customer environmental goals.

Apptronik and Jabil (NYSE: JBL) have announced a strategic collaboration to build Apollo humanoid robots and integrate them into Jabil's manufacturing operations. This partnership aims to create a system where Apollo robots can eventually build more Apollo robots.

As part of the pilot program, newly manufactured Apollo units will undergo real-world validation testing in Jabil's factory environment, performing tasks like inspection, sorting, kitting, and sub-assembly before deployment to Apptronik customers. The humanoids are designed to augment the existing workforce, allowing employees to focus on more creative, thought-intensive projects.

Jabil will serve as the worldwide manufacturing partner for Apollo robots, providing Apptronik with flexibility to scale production globally. Apptronik's design includes unique actuators that require fewer components, less manufacturing time, and lower costs compared to previous generations, making mass production more feasible.

The collaboration aims to make general-purpose humanoids more affordable for expansion into new markets including retail, elder care, and eventually home use.

Pharmaceutics International, Inc. (Pii) has been acquired by Jabil Inc. (NYSE: JBL) in an all-cash transaction for an undisclosed amount. The sale marks the exit of a consortium of investors including Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital, and Pharmascience Inc.

Pii, based in Hunt Valley, Maryland, is a contract development and manufacturing organization specializing in aseptic and sterile injectable pharmaceutical products. The company has provided development and manufacturing services for both NDA and aNDA products for nearly three decades, offering formulation capabilities across virtually all dosage forms and specializing in complex formulations.

The company operates on both a fee-for-service basis for pharmaceutical clients and a profit-share or royalty basis for marketing partners.

Jabil (NYSE: JBL) has successfully acquired Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), on February 3, 2025. Pii's facilities in Hunt Valley, Maryland, span over 360,000 square feet across four sites, featuring over 70 manufacturing rooms specializing in aseptic filling, oral solid dose production, and handling high potency compounds.

The acquisition enhances Jabil's Pharmaceutical Solutions portfolio by adding Pii's capabilities in drug development, clinical trials, and product commercialization. Pii brings expertise in aseptic filling, lyophilization, and oral solid dose manufacturing, complementing Jabil's existing strengths in parenteral drug delivery systems like auto-injectors and inhalers.

Through this acquisition, Pii gains access to Jabil's global infrastructure, automation capabilities, and supply chain efficiencies, while Jabil expands its pharmaceutical manufacturing capabilities and enters the CDMO market.

Jabil (NYSE: JBL) has announced that its Board of Directors has declared a quarterly dividend of $0.08 per share of common stock. The dividend will be paid on March 4, 2025, to shareholders of record as of February 18, 2025. The company highlighted its consistent track record of paying consecutive quarterly cash dividends since May 15, 2006.

Jabil (NYSE: JBL) has announced its upcoming Annual Meeting of Stockholders, which will be held virtually on January 23, 2025, at 10:00 a.m. EST. Stockholders of record as of November 29, 2024 will have full participation rights, including the ability to attend, vote, and ask questions through the online platform at virtualshareholdermeeting.com/JBL2025.

Guests can participate in listen-only mode without requiring a control number. The meeting will be accessible via live audio webcast, with a replay available on Jabil's Investor Relations website.

Jabil (NYSE: JBL) reported strong Q1 FY2025 results with net revenue of $7.0 billion and core diluted EPS of $2.00. The company demonstrated robust performance driven by strength in Cloud, Data Center Infrastructure, and Digital Commerce segments.

For Q2 FY2025, Jabil projects revenue between $6.1-6.7 billion and core diluted EPS of $1.60-2.00. The company raised its FY2025 outlook, now expecting $27.3 billion in net revenue, 5.4% core operating margins, core EPS of $8.75, and adjusted free cash flow of $1.2 billion.

Jabil (NYSE: JBL) has announced it will release its first quarter fiscal year 2025 financial results on Wednesday, December 18, 2024, before market opening. The manufacturing solutions company will host a conference call and webcast at 8:30 a.m. ET to review the results.

Investors can access the call via U.S. dial-in (877) 407-6184 or International (201) 389-0877. The live audio webcast and slide presentation will be available through Jabil's Investor Relations website, with an archived replay accessible after the call.